Overview
Saccharolytic fermentation is the microbial breakdown of carbohydrates (dietary fiber, resistant starch, host glycans) to produce short chain fatty acids (acetate, propionate, butyrate) and gases (H₂, CO₂, CH₄). It is the beneficial fermentation mode — the metabolic activity that produces the protective SCFAs underlying barrier integrity, immune tolerance, and anti-inflammatory signaling throughout this wiki.
Saccharolytic fermentation dominates in the proximal colon where dietary fiber substrates are abundant. As substrates are depleted distally, the microbiome shifts toward proteolytic fermentation (amino acid breakdown), which produces toxic metabolites (hydrogen sulfide, ammonia, p-cresol, phenol, cadaverine).
The Saccharolytic-Proteolytic Balance
| Feature | Saccharolytic | Proteolytic |
|---|---|---|
| Substrate | Fiber, resistant starch | Protein, amino acids |
| Products | SCFAs (beneficial) | H₂S, ammonia, p-cresol (toxic) |
| Location | Proximal colon | Distal colon |
| pH effect | Acidic (protective) | Alkaline (permissive to pathogens) |
| Key taxa | Bacteroides, Prevotella, Bifidobacterium | Desulfovibrio, Fusobacterium, Clostridium |
Low-fiber Western diets shift the balance toward proteolytic fermentation → toxic metabolite accumulation → CRC risk, CKD toxin burden, and barrier damage [1] [2] [3].
Cross-References
- short chain fatty acids — products of saccharolytic fermentation
- dietary fiber — primary substrate
- acetate — most abundant saccharolytic product
- butyrate — most clinically significant saccharolytic product
- hydrogen sulfide — proteolytic fermentation product
- cadaverine — proteolytic fermentation product
- cross feeding — saccharolytic products feed downstream organisms